METHOD FOR MAMMARY GLAND CANCER FORECASTING Russian patent published in 2008 - IPC A61B10/00 G01N33/48 

Abstract RU 2336822 C1

FIELD: medicine.

SUBSTANCE: blood test of patient is carried out. In addition to this following indicators are defined at examination: age, social status, accompanying diseases, quantity of blood monocytes, speed of subsidence of erythrocytes (SSE), total bilirubin of blood, blood creatin, specific weight of urine, urine reaction. Then forecasting index (FI) for each indicator is defined. Age at marker - before 20 years FI equal to (0) is established in the system, at marker 20-29 years - equal to (-10), at marker 30-39 years - equal to (-7), at marker 40-49 years - equal to(+4), at marker 50-59 years - equal to (+3), at marker 60-69 years - equal to (+2), at marker 70-79 years - equal to (+4), at marker 80 and more years - equal to (-3). Social status at marker - workers FI equal to (+4) is established in the system, at marker employees - equal to (-1), at marker pupils - equal to (0), at marker the unemployed - equal to (-12), at marker pensioners and disabled workers (DW) - equal to (+1). Accompanying diseases at marker - diseases of gastroenteric tract (GET) FI equal to (-10) is established in the system, at marker of disease of cardiovascular system - equal to (+2), at marker of disease of endocrine system - equal to (+1.5), at marker of disease of respiratory system - equal to (0), at marker of disease of locomotor apparatus - equal to (0), at marker of disease of urogenital system - equal to (-13), at marker of combination of accompanying diseases - equal to (-1), at marker of absence of accompanying diseases - equal to (+2). Blood monocytes, at marker - not present, FI equal to (0) is established in the system, at marker of 1-3% - equal to (-2.5), at marker of 4-6% - equal to (+2), at marker of 7-10% - equal to (+2.5), at marker more than 10% - equal to (0). Blood sedimentation rate at marker - 1-10 mm per hour FI equal to (-1) is established in the system, at marker of 11-20 mm per hour - equal to (-3), at marker of 21-30 mm per hour - equal to (+7), at marker of 31-40 mm per hour - equal to (0), at marker more than 40 mm per hour - equal to (0). Total bilirubin at marker - less than 8.8 mcmol/l FI equal to (0) is established in the system, at marker of 8.8-17 mcmol per l. - equal to (-1), at marker more than 17 mcmol per l.- equal to (+5.5). Creatinin at marker - less than 0.07 mcmol per l. FI equal to (+11) is established in the system, at marker 0.07-0.17 - equal to (-3), at marker more than 0.17 mcmol/l - equal to (0). Specific weight of urine at marker less-1008 FI equal to (0) is established in the system, at marker 1008-1026 - equal to (+2), at marker more than 1026 - equal to (+6). Urine reaction at marker - sour, FI equal to (+3) is established in the system, at marker neutral - equal to (-3), at marker alkaline - equal to (-12). If FI sum is from (-54.5) to (-21.5) low probability of cancer of mammary gland is predicted, if the sum is from (+11) to (+44.5) high probability of cancer of mammary gland is predicted.

EFFECT: working out simple means of mammary gland cancer diagnostics initially.

4 tbl, 3 ex

Similar patents RU2336822C1

Title Year Author Number
METHOD FOR DIFFERENTIAL DIAGNOSTICS OF MAMMARY GLAND CANCER AND CENTRAL BROKEN BREAST 2007
  • Levchenko Kirill Fedorovich
  • Magarill Jurij Abramovich
  • Belogorlova Tamara Ivanovna
  • Krajushkina Nadezhda Aleksandrovna
RU2336823C1
MEANS FOR BREAST CANCER PREDICTION 2016
  • Malashenko Viktor Nikolaevich
  • Balnykov Sergej Igorevich
  • Sgonnik Anna Vladimirovna
RU2631940C1
METHOD OF PREDICTING RISK OF DEVELOPING TRIPLE-NEGATIVE BREAST CANCER 2023
  • Churnosov Mikhail Ivanovich
  • Pavlova Nadezhda Vitalevna
  • Elykova Anna Vladimirovna
  • Ponomarenko Irina Vasilevna
RU2811257C1
METHOD FOR PREDICTION OF RISK OF DEVELOPING BREAST CANCER IN WOMEN BASED ON DATA ON INTERLOCUS INTERACTIONS 2023
  • Churnosov Mikhail Ivanovich
  • Pasenov Konstantin Nikolaevich
  • Elykova Anna Vladimirovna
  • Ponomarenko Irina Vasilevna
  • Churnosova Mariia Mikhailovna
  • Ponomarenko Marina Sergeevna
  • Churnosov Vladimir Ivanovich
RU2815932C1
METHOD FOR PREDICTING THE RISK OF DEVELOPMENT OF THE LUMINAL SUBTYPE OF BREAST CANCER 2023
  • Churnosov Mikhail Ivanovich
  • Pavlova Nadezhda Vitalevna
  • Elykova Anna Vladimirovna
  • Ponomarenko Irina Vasilevna
RU2795720C1
METHOD FOR PREDICTING THE RISK OF DEVELOPING BREAST CANCER IN WOMEN USING MOLECULAR GENETIC DATA 2022
  • Churnosov Mikhail Ivanovich
  • Pavlova Nadezhda Vitalevna
  • Elykova Anna Vladimirovna
  • Churnosova Mariya Mikhajlovna
RU2795897C1
METHOD FOR PREDICTION OF BREAST CANCER RISK DEVELOPMENT IN OBESE WOMEN 2022
  • Churnosov Mikhail Ivanovich
  • Pavlova Nadezhda Vitalevna
  • Elykova Anna Vladimirovna
RU2795244C1
METHOD FOR PREDICTION OF BREAST CANCER RISK DEVELOPMENT IN NON-OBESE WOMEN 2023
  • Churnosov Mikhail Ivanovich
  • Pavlova Nadezhda Vitalevna
  • Elykova Anna Vladimirovna
  • Ponomarenko Irina Vasilevna
  • Churnosova Mariia Mikhailovna
RU2795726C1
METHOD FOR PREDICTING RISK OF GRADE 3 MALIGNANCY OF TUMOR CELLS IN BREAST CANCER 2023
  • Churnosov Mikhail Ivanovich
  • Pavlova Nadezhda Vitalevna
  • Elykova Anna Vladimirovna
  • Ponomarenko Irina Vasilevna
RU2823459C1
METHOD FOR PREDICTION OF INCREASED RICK OF DEVELOPING STAGE 1-2 BREAST CANCER IN WOMEN BASED ON POLYMORPHISM OF THE MATRIX METALLOPROTEINASE 9 GENE 2022
  • Churnosov Mikhail Ivanovich
  • Pavlova Nadezhda Vitalevna
  • Elykova Anna Vladimirovna
  • Churnosova Mariya Mikhajlovna
RU2795100C1

RU 2 336 822 C1

Authors

Levchenko Kirill Fedorovich

Magarill Jurij Abramovich

Belogorlova Tamara Ivanovna

Krajushkina Nadezhda Aleksandrovna

Dates

2008-10-27Published

2007-04-05Filed